Upperton Limited will be attending the Making Pharmaceuticals Exhibition & Conference at the Ricoh Arena, Coventry from 25-26 April 2017. We would be delighted to hear from any delegates who are interested in learning more about our services and capabilities. Find out more from the conference website
A new 4M8-Trix ProCepT spray dryer has been delivered and is now being commissioned at Upperton. It brings the number of spray dryers that we have in our laboratory and pilot plant to eleven.
A new automated Q5000 SA Dynamic Vapour Sorption analyser (TA Instruments) has been installed in Upperton’s analytical laboratory.
Nottingham, UK – 18th November, 2016 —Upperton is pleased to announce that it has acquired a Quantos MicroDosing unit that can be used to precisely fill a range of dosage forms including capsules, and devices for inhaled and nasal drug delivery. The new Quantos system is capable of dosing to an accuracy of ± 0.5mg, independent of substance characteristics, operator or environmental conditions. The system learns the characteristics of a product, with an RFID chip present in the dosing head storing all the key information on the substance used, including batch number and powder characteristics. Actual fill weights of each individual capsule or device are captured electronically and can be printed if required.
Nottingham, UK – 10th October, 2016 — Upperton is pleased to announce that it is to sponsor the 6th Annual MiBio Conference at Magdalene College, Cambridge (9th November 2016)
Nottingham, UK – 28th May, 2016 — Upperton has entered into a partnership with Quotient Clinical, the Translational Pharmaceutics® Company, to deliver a complete spray drying service for pharmaceutical and biotechnology companies seeking to develop spray dried formulations for clinical use. The partnership will see Upperton working with Quotient Clinical to supply GMP manufacturing services at Quotient within the MediCity life science innovation hub in Nottingham, UK.
Nottingham, UK - 18th May, 2015 - Upperton Ltd, a specialist spray drying and drug formulation company today announced that it has received a significant project grant as part of a consortium looking to evaluate, develop and manufacture thermo stable and cold-chain independent nano-pharmaceutical virosome-based vaccine candidates.